Potential Role of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist in the Treatment of Bulimia Nervosa
Nkechinyere M. Harry, Kenechukwu Anona, Vivien O. Obitulata-Ugwu, Olubukola Anike Kuye, Oluwatosin Arubuolawe, Ibrahim L. Folorunsho, Adeniyi Kayode Busari, Chidalu Ibeneme, Amarachukwu Diala, Victory Afolabi & Gibson O. Anugwom · Journal of Advances in Medicine and Medical Research · 2024
Background: Bulimia nervosa (BN) is a severe eating disorder characterized by recurrent episodes of binge eating followed by compensatory behaviors such as self-induced vomiting, misuse of laxatives, fasting, or excessive exercise. Current treatment strategies, including cognitiv...
Open access
Research Article
10.9734/jammr/2024/v36i75514